Agios Pharmaceuticals Earnings
NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.32
Agios Pharmaceuticals earnings summary
Agios Pharmaceuticals is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $-1.32. In its most recent report on Jul 30, 2026 (Q2 2026), AGIO posted EPS of $-1.69. Revenue for the quarter was $44.7 million.
Across the last 16 reports, AGIO shares moved an average of 7.8% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
AGIO earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 30, 2026 | — | $-1.69 | — | +7.5% |
| Apr 29, 2026 | — | $-1.69 | — | -1.3% |
| Feb 12, 2026 | — | $-1.86 | — | +4.6% |
| Oct 30, 2025 | — | $-1.78 | — | -5.9% |
| Jul 31, 2025 | — | $-1.93 | — | +2.2% |
| May 1, 2025 | — | $-1.55 | — | -9.2% |
| Feb 13, 2025 | — | $-1.44 | — | +6.0% |
| Oct 31, 2024 | — | $16.22 | — | +31.6% |
| Aug 1, 2024 | — | $-1.69 | — | -0.6% |
| May 2, 2024 | — | $-1.45 | — | -4.5% |
| Feb 15, 2024 | — | $-1.71 | — | +24.4% |
| Nov 2, 2023 | — | $-1.64 | — | -6.0% |
| Aug 3, 2023 | — | $-1.51 | — | +4.7% |
| May 4, 2023 | — | $-1.47 | — | -0.6% |
| Feb 23, 2023 | — | $0.68 | — | -2.7% |
| Nov 3, 2022 | — | $-1.49 | — | +13.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.